SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-14-002498
Filing Date
2014-08-13
Accepted
2014-08-13 16:27:30
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT form10q.htm 10-Q 624102
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 17233
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 17213
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 8135
  Complete submission text file 0001493152-14-002498.txt   5379318

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE immy-20140630.xml EX-101.INS 761873
6 XBRL SCHEMA FILE immy-20140630.xsd EX-101.SCH 57099
7 XBRL CALCULATION FILE immy-20140630_cal.xml EX-101.CAL 71414
8 XBRL DEFINITION FILE immy-20140630_def.xml EX-101.DEF 175196
9 XBRL LABEL FILE immy-20140630_lab.xml EX-101.LAB 394526
10 XBRL PRESENTATION FILE immy-20140630_pre.xml EX-101.PRE 275266
Mailing Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130
Business Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130 858-704-4040
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 141037842
SIC: 2834 Pharmaceutical Preparations